Joseph Rucker

Company: Integral Molecular

Job title: VP, Research and Development

Seminars:

Engineering Next-Generation Claudin 6 T-Cell Engagers for Enhanced Specificity & Efficacy 1:45 pm

Navigating the challenges and strategies in developing Claudin 6 T-Cell engagers with high selectivity, minimizing off-target effects on normal tissues Exploring the 2+1 format for Claudin 6 T-Cell engagers, designed to enhance tumor selectivity and reduce toxicity Reviewing preclinical data demonstrating the potential advantages of Claudin 6 T-Cell engagers in treating germ cell cancers, focusing…Read more

day: Conference Day 1